 |
|
|
| |
One-year treatment with elafibranor in the phase III
ELATIVE® trial improves GLOBE and UK-PBC prognostic scores
|
| |
| |
AASLD 2024 The Liver Meeting® | November 15-19, 2024 | San Diego, CA, USA.
Kris V. Kowdley,1 Eric Lawitz,2 Mark Sonderup,3 C. Wendy Spearman,3 Vincenza Calvaruso,4 Nuno Antunes,5 Jianfen Shu,5 Claudia O. Zein,5* Christopher L. Bowlus6
|
| |
|
|
|
|
|
